리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 02월
페이지 정보:영문 212 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 나노바이오테크놀러지 시장, 2030년에는 1,788억 달러에 도달
2024년에 1,194억 달러로 추정되는 세계의 나노바이오테크놀러지 시장은 2030년에는 1,788억 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 7.0%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 의약품·바이오테크놀러지 산업 최종 사용은 CAGR 7.6%를 기록하며, 분석 기간 종료시에는 1,227억 달러에 달할 것으로 예측됩니다. 의료기기 최종 사용 분야의 성장률은 분석 기간 중 CAGR 5.7%로 추정됩니다.
미국 시장은 332억 달러, 중국은 CAGR 6.5%로 성장 예측
미국의 나노바이오테크놀러지 시장은 2024년에 332억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 276억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 6.5%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 6.6%와 5.3%로 예측됩니다. 유럽에서는 독일이 CAGR 5.6%로 성장할 것으로 예측됩니다.
세계의 나노 필름 시장 - 주요 동향과 촉진요인 정리
나노필름이란 무엇이며, 어떻게 산업에 혁명을 가져올 것인가?
나노 필름은 기능성과 성능을 향상시키기 위해 표면에 적용되는 수 나노미터 두께의 초박막입니다. 이 필름은 금속, 세라믹, 폴리머 등 다양한 재료로 구성되어 있으며, 각각 높은 전도성, 뛰어난 강도, 내식성, 내마모성 등 고유한 특성을 가지고 있습니다. 그 용도는 전자, 의료, 에너지, 자동차 등 다양한 산업 분야에 걸쳐 광범위하게 적용되고 있습니다. 예를 들어 전자 분야에서 나노필름은 화면의 밝기와 색채 품질을 향상시켜 스마트폰, TV 등 기기의 효율과 성능을 향상시키는 데 사용됩니다. 헬스케어 분야에서 나노필름은 보다 효율적인 약물전달 시스템 및 첨단 진단 툴 개발에 기여하고 있습니다.
기술의 발전은 나노 필름 개발에 어떤 영향을 미치고 있는가?
기술의 발전은 나노필름의 개발, 특히 제조 및 응용에 사용되는 방법에서 매우 중요한 역할을 하고 있습니다. 원자층 증착(ALD), 화학기상증착(CVD), 물리적 기상 성장(PVD) 등의 기술을 통해 필름의 두께와 조성을 정밀하게 제어할 수 있으며, 특정 산업 수요에 맞는 맞춤형 솔루션을 제공할 수 있습니다. 나노테크놀러지의 혁신은 온도, 빛, 압력 등 환경 자극에 반응할 수 있는 스마트 나노필름의 개발로 이어지고 있습니다. 이러한 반응성 필름은 센서 및 웨어러블 기술에 점점 더 많이 사용되고 있으며, 디바이스의 기능성과 사용자 상호작용을 향상시키는 적응 특성을 제공합니다.
나노필름의 미래를 좌우할 시장 동향은?
나노필름 시장은 수요 및 공급 역학에 영향을 미치는 몇 가지 중요한 동향에 의해 형성되고 있습니다. 가장 큰 동향 중 하나는 고성능, 소형화된 전자기기에 대한 수요가 증가하고 있다는 점입니다. 디바이스가 소형화되고 기능이 향상됨에 따라 더 작은 크기로 더 높은 성능을 발휘할 수 있는 첨단 소재에 대한 필요성이 증가하고 있습니다. 나노 박막은 얇은 층으로 고성능을 구현함으로써 이러한 요구를 충족시켜 소형 전자기기에 이상적인 소재가 되고 있습니다. 또 다른 추세는 지속가능성에 대한 관심이 높아지면서 태양전지판이나 에너지 효율이 높은 창문에 사용되는 것과 같이 에너지 효율에 기여하는 나노 필름에 대한 관심이 높아지고 있습니다. 또한 자동차 산업이 전기자동차로 전환함에 따라 가볍고 내구성이 뛰어난 소재에 대한 수요가 증가하고 있으며, 나노필름은 배터리 수명과 자동차의 성능을 향상시키는 데 사용되고 있습니다.
나노필름 시장 성장의 원동력은?
나노필름 시장의 성장은 나노테크놀러지과 재료과학의 지속적인 발전, 다양한 산업에서 나노필름의 품질과 적용성 향상 등 여러 가지 요인에 의해 이루어지고 있습니다. 더 작고, 더 빠르고, 더 효율적인 장비에 대한 끊임없는 요구로 호황을 누리고 있는 전자 분야는 이러한 요구를 충족시키기 위해 나노 필름 기술에 크게 의존하고 있습니다. 또한 에너지 분야, 특히 태양에너지 용도에서 나노필름의 활용이 증가하고 있으며, 세계가 재생한 에너지원으로 이동함에 따라 시장 성장을 지원하고 있습니다. 특히 고성능, 내구성, 에너지 효율이 높은 제품을 찾는 소비자가 증가하고 있기 때문입니다. 또한 환경 지속가능성을 촉진하는 규제 동향은 환경 부하를 줄이는 데 도움이 되는 나노 필름과 같은 혁신적인 재료의 채택을 장려하고 있습니다. 이러한 요인들이 종합적으로 나노필름 시장의 역동적인 성장을 촉진하고 있으며, 이는 현대 기술 응용에서 나노필름의 필수적인 역할을 반영하고 있습니다.
부문
최종 용도(제약 및 생명공학 산업, 의료기기)
조사 대상 기업의 예(총 79건)
Ablynx NV
Arrowhead Pharmaceuticals Inc.
CaPtivate Pharmaceuticals LLC
Celgene Corporation
ELITechGroup
Flamel Technologies SA
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co. Inc.
NanoBio(R) Corporation
Nanophase Technologies Corporation
pSivida Corp.
Sigma-Aldrich Corp.
Starpharma Holdings Ltd.
Vectura Group plc
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장의 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSA
영문 목차
영문목차
Global Nanobiotechnology Market to Reach US$178.8 Billion by 2030
The global market for Nanobiotechnology estimated at US$119.4 Billion in the year 2024, is expected to reach US$178.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry End-Use, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the analysis period. Growth in the Medical Devices End-Use segment is estimated at 5.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$33.2 Billion While China is Forecast to Grow at 6.5% CAGR
The Nanobiotechnology market in the U.S. is estimated at US$33.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.
Global Nanofilms Market - Key Trends & Drivers Summarized
What Are Nanofilms and How Are They Revolutionizing Industries?
Nanofilms are ultra-thin layers of material, often just a few nanometers thick, applied to surfaces to enhance their functionality or performance. These films can be composed of different materials, including metals, ceramics, and polymers, each offering unique properties such as high conductivity, exceptional strength, and resistance to corrosion and wear. Their applications are diverse and span across industries including electronics, healthcare, energy, and automotive. In electronics, for instance, nanofilms are used to improve the efficiency and performance of devices like smartphones and TVs by enhancing screen brightness and color quality. In the healthcare sector, nanofilms contribute to the development of more efficient drug delivery systems and advanced diagnostic tools.
How Are Technological Advancements Influencing Nanofilm Developments?
Technological advancements play a pivotal role in the development of nanofilms, particularly in the methods used for their fabrication and application. Techniques such as atomic layer deposition (ALD), chemical vapor deposition (CVD), and physical vapor deposition (PVD) allow for precise control over the thickness and composition of these films, enabling tailor-made solutions for specific industry needs. Innovations in nanotechnology have also led to the creation of smart nanofilms, which can respond to environmental stimuli such as temperature, light, and pressure. These responsive films are increasingly used in sensors and wearable technology, offering adaptive properties that enhance device functionality and user interaction.
What Market Trends Are Shaping the Future of Nanofilms?
The nanofilm market is being shaped by several significant trends that are influencing both demand and supply dynamics. One of the major trends is the increasing demand for high-performance, miniaturized electronics. As devices become smaller and their functionality increases, the need for advanced materials that can perform at these reduced dimensions grows. Nanofilms meet these requirements by enabling high performance in thin layers, making them ideal for compact electronic devices. Another trend is the growing focus on sustainability, driving interest in nanofilms that contribute to energy efficiency, such as those used in solar panels and energy-efficient windows. Additionally, the automotive industry's shift towards electric vehicles has increased the need for lightweight, durable materials, where nanofilms are used to enhance battery life and vehicle performance.
What Drives the Growth of the Nanofilm Market?
The growth in the nanofilm market is driven by several factors, including the continued advancement of nanotechnology and material science, which enhances the quality and applicability of nanofilms across various industries. The booming electronics sector, with its constant demand for smaller, faster, and more efficient devices, heavily relies on nanofilm technology to meet these requirements. Additionally, the increasing utilization of nanofilms in the energy sector, particularly in solar energy applications, supports market growth as the world moves towards more renewable energy sources. Consumer behavior also influences this growth, especially as more consumers demand high-performance, durable, and energy-efficient products. Moreover, regulatory trends promoting environmental sustainability encourage the adoption of innovative materials like nanofilms to help reduce environmental impact. These factors collectively drive the dynamic expansion of the nanofilm market, reflecting its integral role in modern technological applications.
SCOPE OF STUDY:
The report analyzes the Nanobiotechnology market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
End-Use (Pharmaceuticals & Biotechnology Industry, Medical Devices)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 79 Featured) -
Ablynx NV
Arrowhead Pharmaceuticals Inc.
CaPtivate Pharmaceuticals LLC
Celgene Corporation
ELITechGroup
Flamel Technologies SA
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co. Inc.
NanoBio(R) Corporation
Nanophase Technologies Corporation
pSivida Corp.
Sigma-Aldrich Corp.
Starpharma Holdings Ltd.
Vectura Group plc
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Nanobiotechnology - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Advances in Nanotechnology Propel Growth in Nanobiotechnology Market
Increasing Demand for Targeted Drug Delivery Expands Addressable Market Opportunity
Growth in Diagnostic and Imaging Applications Generates Demand for Nanobiotechnology Solutions
Technological Innovations in Nanomedicine Strengthen Business Case for Nanobiotechnology
Integration of Nanomaterials in Regenerative Medicine Spurs Growth in Healthcare Sector
Demand for Precision Medicine Expands the Market for Nanobiotechnology
Advances in Nano-Scale Imaging and Sensing Technologies Generate Demand for Innovative Solutions
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 11: USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 12: USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: USA 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
CANADA
TABLE 14: Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 15: Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: Canada 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
JAPAN
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 17: Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 18: Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: Japan 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
CHINA
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 20: China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: China 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
EUROPE
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 23: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: Europe 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 26: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
FRANCE
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 29: France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: France 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
GERMANY
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 32: Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: Germany 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
ITALY
TABLE 35: Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: Italy 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
UNITED KINGDOM
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 38: UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: UK 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: Rest of Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: Asia-Pacific 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 47: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Rest of World 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030